EP 3869965 A1 20210901 - ZINC MOLYBDATE HAVING A TRICLINIC CRYSTAL STRUCTURE, AS AN ANTIMICROBIAL AGENT
Title (en)
ZINC MOLYBDATE HAVING A TRICLINIC CRYSTAL STRUCTURE, AS AN ANTIMICROBIAL AGENT
Title (de)
ZINKMOLYBDAT MIT TRIKLINER KRISTALLSTRUKTUR ALS ANTIMIKROBIELLER WIRKSTOFF
Title (fr)
MOLYBDATE DE ZINC À STRUCTURE CRISTALLINE TRICLINIQUE UTILISÉ COMME AGENT ANTIMICROBIEN
Publication
Application
Priority
- EP 18202862 A 20181026
- EP 2019079301 W 20191025
Abstract (en)
[origin: CA3158369A1] The invention relates to the use of a triclinic form of zinc molybdate (Zn Mo O4) as an antimicrobial agent, to composite materials comprising said zinc molybdate and to processes for preparing same.
IPC 8 full level
A01N 59/16 (2006.01); A01N 25/08 (2006.01); A01P 1/00 (2006.01)
CPC (source: EP KR US)
A01N 25/08 (2013.01 - KR US); A01N 25/12 (2013.01 - US); A01N 59/16 (2013.01 - EP KR US)
C-Set (source: EP)
Citation (search report)
See references of WO 2020084155A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
EP 3643177 A1 20200429; BR 112021013631 A2 20211109; CA 3158369 A1 20200430; CN 113316390 A 20210827; DE 202019005334 U1 20200417; EP 3869965 A1 20210901; JP 2022509569 A 20220120; KR 20210110795 A 20210909; SG 11202106767T A 20210729; US 2022007649 A1 20220113; WO 2020084155 A1 20200430; WO 2020084155 A9 20210729
DOCDB simple family (application)
EP 18202862 A 20181026; BR 112021013631 A 20191025; CA 3158369 A 20191025; CN 201980086418 A 20191025; DE 202019005334 U 20191025; EP 19790230 A 20191025; EP 2019079301 W 20191025; JP 2021554787 A 20191025; KR 20217015908 A 20191025; SG 11202106767T A 20191025; US 201917288792 A 20191025